about
Anti-inflammatory and immunoregulatory functions of artemisinin and its derivativesArtesunate abolishes germinal center B cells and inhibits autoimmune arthritisIL-33 induces nuocytes and modulates liver injury in viral hepatitis.SerpinB1 Promotes Pancreatic β Cell ProliferationParenchymal expression of CD40 exacerbates adenovirus-induced hepatitis in mice.Type 1 interferon-induced IL-7 maintains CD8+ T-cell responses and homeostasis by suppressing PD-1 expression in viral hepatitisSerpinB1 regulates homeostatic expansion of IL-17+ γδ and CD4+ Th17 cells.Intrahepatic innate lymphoid cells secrete IL-17A and IL-17F that are crucial for T cell priming in viral infection.Immune suppressive properties of artemisinin family drugs.IL-33 promotes innate IFN-γ production and modulates dendritic cell response in LCMV-induced hepatitis in miceAnti-inflammatory natural products.Periplocoside A, a pregnane glycoside from Periploca sepium Bge, prevents concanavalin A-induced mice hepatitis through inhibiting NKT-derived inflammatory cytokine productions.Anti-Inflammatory and Immunostimulatory Activities of Astragalosides.Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses.Volatile anesthetics affect macrophage phagocytosisMedical Plants and Immunological Regulation.Suppressive effect of a novel water-soluble artemisinin derivative SM905 on T cell activation and proliferation in vitro and in vivoAlleviation of picryl chloride-induced delayed type hypersensitivity reaction by saponin fraction of Gleditsia sinensisThe volatile anesthetic sevoflurane reduces neutrophil apoptosis via Fas death domain-Fas-associated death domain interaction
P50
Q28083774-55BBEF52-AB3B-4F68-9489-350FAFD4A4E2Q28541811-26616412-85B0-4B4E-AEA7-DD441E01E34DQ28588039-A5C35D09-72FC-4837-AE88-EF5F3C295EE9Q30354433-556325BD-83BA-459D-ADD2-1E7D762BB1C3Q34860648-F21E5ECB-2FB3-4032-9C45-B5BFA274CDFCQ36302605-7CC28992-83A5-4191-83BD-97705BC9ADF3Q37581430-ABC79B51-BB46-4C45-82E0-3CA549040A27Q37668196-3B926707-ECE9-4159-9494-CDFCD145363BQ38895489-10996304-C1A9-4DEF-8949-EF9738455936Q39673177-F375A522-118B-4FCF-9022-CA8B24AC04F2Q40527659-0753FA5E-6588-4C94-92E1-56481F27B20CQ46501500-997A595F-BA13-43D4-9EC1-467AA18DFC59Q47920679-CCCEEDE7-7D72-4E23-87A8-34E92E842F3AQ51477256-6910BB44-79E6-4E77-8244-3B936076982AQ64060953-FD225BB1-AD13-45C2-8541-2AAAA2D0AAD4Q64899778-13B26637-2642-406F-B7A8-D959A9E958A3Q79915322-8CBB9BBB-90C6-4461-AF1E-F050E18FC9D1Q83229459-E0593358-E1E0-476F-808C-3E0E4B918B86Q90075989-EE02A2AC-21E5-43F2-B1E8-282CB6668D6C
P50
description
investigador
@es
researcher
@en
name
Li-Fei Hou
@en
Li-Fei Hou
@nl
type
label
Li-Fei Hou
@en
Li-Fei Hou
@nl
prefLabel
Li-Fei Hou
@en
Li-Fei Hou
@nl
P31
P496
0000-0001-8975-7795